Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

24
Scaling Up Retinal Screening in an HIV clinic in Nanning, China to prevent blindness from CMV retinitis Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU) Operational Centre Brussels (OCB) Médecins Sans Frontières (MSF) Advances and Opportunities to Address CMV retinitis Satellite Symposium IAS Conference 30 June 2013

description

Scaling Up Retinal Screening in an HIV clinic in Nanning, China to prevent blindness from CMV retinitis . Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU) Operational Centre Brussels (OCB) Médecins Sans Frontières (MSF). Advances and Opportunities to - PowerPoint PPT Presentation

Transcript of Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Page 1: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Scaling Up Retinal Screeningin an HIV clinic in Nanning, China

to prevent blindness from CMV retinitis

Peter Saranchuk, MDTB-HIV Adviser

Southern Africa Medical Unit (SAMU)Operational Centre Brussels (OCB)

Médecins Sans Frontières (MSF)

Advances and Opportunities to Address CMV retinitisSatellite SymposiumIAS Conference30 June 2013

Page 2: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)
Page 3: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

HIV late presenters

31.8%

Of people present for the first time with a CD4 count < 200 cells/µL

Page 4: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

CMV: The 3rd most common/serious OI

Page 5: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Prior to Nov 2008 in Nanning

Problem: Diagnosis of CMV usually delayed

– Retinal screening not done– Diagnosis made only after vision loss had

already occurred– Irreversible– Required referral to a secondary hospital

Page 6: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Poor Outcomes (prior to Nov 2008)

• Of 17 patients assessed in Nov 2008 and found to have active or inactive CMV retinitis:– 5 (29%) had bilateral involvement– 7/11 eyes (64%) with inactive disease were

blind*

* <20/400 visual acuity and/or able to count fingers at 10 feet

Page 7: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Solution

Page 8: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Training in retinal examination

Over 4days

• By an ophthalmologist (D. Heiden)• Of HIV clinicians• In the use of an indirect ophthalmoscope (IO)• E-mail address given for follow-up support

Page 9: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)
Page 10: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Ophthalmoscopy

The key to both = use dilating drops

IndirectDirec

tVs.

Page 11: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

After Nov 2008 in Nanning

•Retinal screening–Performed routinely– In all at-risk patients (e.g. those with CD4<100)– By HIV clinicians– Using an indirect ophthalmoscope– In the HIV clinic

Page 12: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

CMV retinitis has a typical pattern

Page 13: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

After Nov 2008

• Now able to diagnose CMV retinitis:– At the first visit– Within minutes– Inexpensively– At primary HIV care level– More easily than other common, serious OIs!

Page 14: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

After Nov 2008

• Now able to diagnose CMV retinitis:– At the first visit– Within minutes– Inexpensively– At primary HIV care level– More easily than other common, serious OIs!

•= A point-of-care diagnostic!

Page 15: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Every HIV clinic should have…

• A bottle of drops to dilate pupils• E.g. Tropicamide

Page 16: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Ophthalmologists still involved

• Telemedicine– E-mailing of digital retinal images

• Complicated cases– Immune Recovery Uveitis (I.e. IRIS)– Retinal detachment

Page 17: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

After Nov 2008• Routine retinal screening• Earlier diagnosis• Earlier treatment • Improved visual outcomes

– E.g. Minority of patients now being diagnosed with CMV retinitis are blind

Page 18: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Subsequent Trainings

Page 19: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Average duration of treatment in Nanning

~4.5 months

N.B.: ART needs to be initiated as soon as possible

Page 20: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Usual Treatment: Sticking needles into eyes!

Page 21: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Price of valganciclovir needs to be…

<1 dollar per tablet

to prevent CMV-related blindnessand encourage retinal screening

Page 22: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Conclusions1. Retinal screening performed routinely

prevents CMV-related blindness2. Can be done by trained HIV clinicians

– In resource-limited settings3. Diagnosis of CMV retinitis then becomes

easier than other OIs!4. Need a treatment which is both

convenient and affordable

Page 23: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Acknowledgments

• Dr. David Heiden• Pacific Vision Foundation• Seva Foundation• Chinese partners

–Guangxi CDC–The Fourth Hospital of Nanning

Page 24: Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU)

Treatment options in Nanning

• Intravitreal injections (weekly)– Inexpensive– Barbaric!

• I.v. ganciclovir (daily)– Expensive– Inpatient vs. outpatient?

• Oral valganciclovir (VG)– Convenient– Outrageously expensive (~40 USD per tablet)